Back to my company list

Biodesix

The AI engine Fit Assessment

Beta

Biodesix leverages machine learning and multi-technology approaches to enhance therapeutic options and identify biomarkers, driving personalized medicine in lung cancer diagnostics.

Blurb

Biodesix is a data-driven diagnostic solutions company that provides lung cancer diagnostic testing and biopharma services.

HQ Location

Broomfield (United States)

Founded

2005

Employees

201 - 500

Total funding raised

$917.77M

Funding Status

Post-IPO Equity, $55.00M, April 5, 2024
Subspaces
  • Biomarker Identification

Biodesix is a leading diagnostics solutions company, driven to improve clinical care and outcomes for patients.



Biodesix Diagnostic Tests support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease.



Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics.

 

Our culture:

The foundation of Biodesix workplace culture is based on these operating principles: TEAM. IMPACT. EXCELLENCE. Based on anonymous team member surveys, Biodesix has been awarded Inc. Magazine's 2024 Best Workplaces and The Denver Post's 2025 Top Workplaces - https://topworkplaces.com/company/biodesix/

 

#bdsx #biodesix #lungcancer  #biopharma #lifesciences #diagnostics #proteomics #genomics #multiomics #radiomics #medicalAI #liquidbiopsy #digitaldiagnostics #oncology #lungcancer